Literature DB >> 8794360

Human immunodeficiency virus type 1 nucleocapsid protein reduces reverse transcriptase pausing at a secondary structure near the murine leukemia virus polypurine tract.

W Wu1, L E Henderson, T D Copeland, R J Gorelick, W J Bosche, A Rein, J G Levin.   

Abstract

In an earlier study on minus-strand DNA synthesis catalyzed by murine leukemia virus reverse transcriptase, we described a prominent pause site near the polypurine tract (J. Guo, W. Wu, Z. Y. Yuan, K. Post, R. J. Crouch, and J. G . Levin, Biochemistry 34:5018-5029, 1995). We now report that pausing at this site is due to a stem-loop structure in the RNA template, formed by interaction of a number of bases in the polypurine tract, including the six G's, and a 3' sequence which includes four C's. Addition of human immunodeficiency virus type 1 (HIV-1) nucleocapsid (NC) protein to reverse transcriptase reactions reduces pausing by approximately 8- to 10-fold and stimulates synthesis of full-length DNA. Thus, NC functions as an accessory protein during elongation of minus-strand DNA and increases the efficiency of DNA synthesis, in this case, by apparently destabilizing a region of secondary structure in the template. Since NC is associated with genomic RNA in the viral core and is likely to be part of a viral replication complex, these results suggest that NC may also promote efficient DNA synthesis during virus replication. Mutational analysis indicates that the features of HIV-1 NC which are important for reduction of pausing include the basic amino acids flanking the first zinc finger, the zinc fingers, and the cysteine and aromatic amino acids within the fingers. These findings suggest that reverse transcription might be targeted by drugs which inactivate the zinc fingers of HIV-1 NC.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8794360      PMCID: PMC190766     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  77 in total

1.  The nucleocapsid protein isolated from HIV-1 particles binds zinc and forms retroviral-type zinc fingers.

Authors:  T L South; P R Blake; R C Sowder; L O Arthur; L E Henderson; M F Summers
Journal:  Biochemistry       Date:  1990-08-28       Impact factor: 3.162

2.  HIV-1 nucleocapsid protein induces "maturation" of dimeric retroviral RNA in vitro.

Authors:  Y X Feng; T D Copeland; L E Henderson; R J Gorelick; W J Bosche; J G Levin; A Rein
Journal:  Proc Natl Acad Sci U S A       Date:  1996-07-23       Impact factor: 11.205

3.  Point mutations in the proximal Cys-His box of Rous sarcoma virus nucleocapsid protein.

Authors:  P Dupraz; S Oertle; C Meric; P Damay; P F Spahr
Journal:  J Virol       Date:  1990-10       Impact factor: 5.103

4.  Characterization of human immunodeficiency virus type 1 dimeric RNA from wild-type and protease-defective virions.

Authors:  W Fu; R J Gorelick; A Rein
Journal:  J Virol       Date:  1994-08       Impact factor: 5.103

5.  Retroviral nucleocapsid proteins possess potent nucleic acid strand renaturation activity.

Authors:  F Dib-Hajj; R Khan; D P Giedroc
Journal:  Protein Sci       Date:  1993-02       Impact factor: 6.725

6.  Mutations of basic amino acids of NCp7 of human immunodeficiency virus type 1 affect RNA binding in vitro.

Authors:  E Schmalzbauer; B Strack; J Dannull; S Guehmann; K Moelling
Journal:  J Virol       Date:  1996-02       Impact factor: 5.103

7.  Phosphorescence and optically detected magnetic resonance investigation of the binding of the nucleocapsid protein of the human immunodeficiency virus type 1 and related peptides to RNA.

Authors:  W C Lam; A H Maki; J R Casas-Finet; J W Erickson; B P Kane; R C Sowder; L E Henderson
Journal:  Biochemistry       Date:  1994-09-06       Impact factor: 3.162

8.  Nucleocapsid protein effects on the specificity of retrovirus RNA encapsidation.

Authors:  Y Zhang; E Barklis
Journal:  J Virol       Date:  1995-09       Impact factor: 5.103

9.  Transactivation of the minus-strand DNA transfer by nucleocapsid protein during reverse transcription of the retroviral genome.

Authors:  B Allain; M Lapadat-Tapolsky; C Berlioz; J L Darlix
Journal:  EMBO J       Date:  1994-02-15       Impact factor: 11.598

10.  Facilitation of hammerhead ribozyme catalysis by the nucleocapsid protein of HIV-1 and the heterogeneous nuclear ribonucleoprotein A1.

Authors:  E L Bertrand; J J Rossi
Journal:  EMBO J       Date:  1994-06-15       Impact factor: 11.598

View more
  68 in total

1.  Effect of distance between homologous sequences and 3' homology on the frequency of retroviral reverse transcriptase template switching.

Authors:  K A Delviks; V K Pathak
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

2.  Identification of residues of the Moloney murine leukemia virus nucleocapsid critical for viral DNA synthesis in vivo.

Authors:  J Gonsky; E Bacharach; S P Goff
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

3.  The human immunodeficiency virus type 1 Gag polyprotein has nucleic acid chaperone activity: possible role in dimerization of genomic RNA and placement of tRNA on the primer binding site.

Authors:  Y X Feng; S Campbell; D Harvin; B Ehresmann; C Ehresmann; A Rein
Journal:  J Virol       Date:  1999-05       Impact factor: 5.103

4.  A mimic of HIV-1 nucleocapsid protein impairs reverse transcription and displays antiviral activity.

Authors:  S Druillennec; C Z Dong; S Escaich; N Gresh; A Bousseau; B P Roques; M C Fournié-Zaluski
Journal:  Proc Natl Acad Sci U S A       Date:  1999-04-27       Impact factor: 11.205

5.  Subtle alterations of the native zinc finger structures have dramatic effects on the nucleic acid chaperone activity of human immunodeficiency virus type 1 nucleocapsid protein.

Authors:  Jianhui Guo; Tiyun Wu; Bradley F Kane; Donald G Johnson; Louis E Henderson; Robert J Gorelick; Judith G Levin
Journal:  J Virol       Date:  2002-05       Impact factor: 5.103

6.  Experimental determination and calculations of redox potential descriptors of compounds directed against retroviral zinc fingers: Implications for rational drug design.

Authors:  I A Topol; C McGrath; E Chertova; C Dasenbrock; W R Lacourse; M A Eissenstat; S K Burt; L E Henderson; J R Casas-Finet
Journal:  Protein Sci       Date:  2001-07       Impact factor: 6.725

7.  Determinants of the human immunodeficiency virus type 1 p15NC-RNA interaction that affect enhanced cleavage by the viral protease.

Authors:  N Sheng; S C Pettit; R J Tritch; D H Ozturk; M M Rayner; R Swanstrom; S Erickson-Viitanen
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

8.  Specific cleavages by RNase H facilitate initiation of plus-strand RNA synthesis by Moloney murine leukemia virus.

Authors:  Sharon J Schultz; Miaohua Zhang; James J Champoux
Journal:  J Virol       Date:  2003-05       Impact factor: 5.103

9.  Thermophilic bacterial DNA polymerases with reverse-transcriptase activity.

Authors:  Harini Shandilya; Kate Griffiths; Elizabeth K Flynn; Mekbib Astatke; Po-Jen Shih; Jun E Lee; Gary F Gerard; Moreland D Gibbs; Peter L Bergquist
Journal:  Extremophiles       Date:  2004-04-09       Impact factor: 2.395

Review 10.  Role of HIV-1 nucleocapsid protein in HIV-1 reverse transcription.

Authors:  Judith G Levin; Mithun Mitra; Anjali Mascarenhas; Karin Musier-Forsyth
Journal:  RNA Biol       Date:  2010-11-01       Impact factor: 4.652

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.